Research Site — Washington D.C., District of Columbia

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

638

Registered studies

223

Active

Recruiting now

331

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer · Non-Small Cell Lung Cancer (NSCLC) · Carcinoma, Non-Small-Cell Lung · Bronchiectasis With Pseudomonas Aeruginosa Colonization

Recently updated registry entries

NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT06901531 — A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… (Recruiting)
NCT05382559 — A Study of ASP3082 in Adults With Advanced Solid Tumors (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.